- Home
- GRAL vs QSI Comparison
GRAL vs QSI Comparison
Compare GRAL & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- QSI
- Stock Information
- Founded
- GRAL 2016
- QSI 2013
- Country
- GRAL United States
- QSI United States
- Employees
- GRAL N/A
- QSI N/A
- Industry
- GRAL
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- GRAL
- QSI Health Care
- Exchange
- GRAL NYSE
- QSI Nasdaq
- Market Cap
- GRAL 1.3B
- QSI 219.8M
- IPO Year
- GRAL N/A
- QSI N/A
- Fundamental
- Price
- GRAL $46.87
- QSI $2.11
- Analyst Decision
- GRAL Buy
- QSI Strong Buy
- Analyst Count
- GRAL 3
- QSI 3
- Target Price
- GRAL $31.50
- QSI $2.38
- AVG Volume (30 Days)
- GRAL 1.6M
- QSI 8.4M
- Earning Date
- GRAL 08-12-2025
- QSI 08-06-2025
- Dividend Yield
- GRAL N/A
- QSI N/A
- EPS Growth
- GRAL N/A
- QSI N/A
- EPS
- GRAL N/A
- QSI N/A
- Revenue
- GRAL $130,711,000.00
- QSI $3,443,000.00
- Revenue This Year
- GRAL $19.52
- QSI $77.57
- Revenue Next Year
- GRAL $20.37
- QSI $251.34
- P/E Ratio
- GRAL N/A
- QSI N/A
- Revenue Growth
- GRAL 30.47
- QSI 167.94
- 52 Week Low
- GRAL $12.33
- QSI $0.61
- 52 Week High
- GRAL $63.99
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- QSI 65.03
- Support Level
- GRAL N/A
- QSI $1.87
- Resistance Level
- GRAL N/A
- QSI $2.14
- Average True Range (ATR)
- GRAL 0.00
- QSI 0.14
- MACD
- GRAL 0.00
- QSI 0.02
- Stochastic Oscillator
- GRAL 0.00
- QSI 93.65
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.